tecentriq

Generic: atezolizumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name tecentriq
Generic Name atezolizumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

atezolizumab 1200 mg/20mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-917
Product ID 50242-917_090baf8e-6c5c-4021-a54c-7373d4df1759
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761034
Listing Expiration 2026-12-31
Marketing Start 2016-05-18

Pharmacologic Class

Established (EPC)
programmed death receptor-1 blocking antibody [epc]
Mechanism of Action
programmed death receptor-1-directed antibody interactions [moa]
Chemical Structure
antibodies, monoclonal, humanized [cs] antibodies, monoclonal [cs] antibodies [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242917
Hyphenated Format 50242-917

Supplemental Identifiers

RxCUI
1792780 1792785 2119695 2119696
UNII
52CMI0WC3Y
NUI
N0000191260 N0000191259 M0556300 M0001357 M0001352

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tecentriq (source: ndc)
Generic Name atezolizumab (source: ndc)
Application Number BLA761034 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1200 mg/20mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1 VIAL, SINGLE-USE
  • 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

50242-917-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1 VIAL, SINGLE-USE 50242-917-86 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

atezolizumab (1200 mg/20mL)

Linked Drug Pages (1)

TECENTRIQ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "090baf8e-6c5c-4021-a54c-7373d4df1759", "openfda": {"nui": ["N0000191260", "N0000191259", "M0556300", "M0001357", "M0001352"], "unii": ["52CMI0WC3Y"], "rxcui": ["1792780", "1792785", "2119695", "2119696"], "spl_set_id": ["6fa682c9-a312-4932-9831-f286908660ee"], "pharm_class_cs": ["Antibodies, Monoclonal, Humanized [CS]", "Antibodies, Monoclonal [CS]", "Antibodies [CS]"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-917-01", "marketing_start_date": "20160518"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-917-86", "marketing_start_date": "20160811"}], "brand_name": "TECENTRIQ", "product_id": "50242-917_090baf8e-6c5c-4021-a54c-7373d4df1759", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies [CS]", "Antibodies", "Monoclonal [CS]", "Antibodies", "Monoclonal", "Humanized [CS]", "Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "50242-917", "generic_name": "atezolizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TECENTRIQ", "active_ingredients": [{"name": "ATEZOLIZUMAB", "strength": "1200 mg/20mL"}], "application_number": "BLA761034", "marketing_category": "BLA", "marketing_start_date": "20160518", "listing_expiration_date": "20261231"}